Compound ID | 1066

Update compound information

Alafosfalin

Class: Small molecule antibacterial agent

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-negative
Mechanism of action: Cell wall synthesis inhibitor
Target Pathogen: Active against Enterobacteriaceae
Propensity to select resistant mutants: Yes
Description: A phosphonodipeptide
Institute where first reported: Roche Products Limitted
Year first mentioned: 1979
Highest development stage: Clinical trial
Development status: Inactive
Reason dropped: Therapeutic usefulness limited by selection of resistant mutants
Chemical structure(s):
Click here for structure editor
Molecular weight: 196.14
Iso. SMILES: CC(C(=O)NC(C)P(=O)(O)O)N
InChI Key: BHAYDBSYOBONRV-UHFFFAOYSA-N
Can. SMILES: CC(C(=O)NC(C)P(=O)(O)O)N
InChI: InChI=1S/C5H13N2O4P/c1-3(6)5(8)7-4(2)12(9,10)11/h3-4H,6H2,1-2H3,(H,7,8)(H2,9,10,11)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/71957
Guide to Pharmacology: alafosfalin
Citations:
  • https://doi.org/10.1128/aac.16.3.306
  • https://doi.org/10.1128/aac.17.6.973

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.